From: Foxp3 overexpression in tumor cells predicts poor survival in oral squamous cell carcinoma
Characteristics | 5-years OS rate (95 % CI) | P Value | 5-year RFS rate (95 % CI) | P Value |
---|---|---|---|---|
T stage | ||||
T1-T2 | 0.415 (0.256–0.574) | 0.212 | 0.652 (0.540–0.764) | 0.034* |
T3-T4 | 0.252 (−0.101–0.605) | 0.713 (0.448–0.978) | ||
N stage | ||||
N0 | 0.470 (0.290–0.650) | 0.000*** | 0.671 (0.548–0.794) | 0.584 |
N1-N3 | 0.252 (−0.101–0.605) | 0.733 (0.623–0.843) | ||
Clinical stage | ||||
I-II | 0.437 (0.249–0.625) | 0.012* | 0.627 (0.502–0.752) | 0.043* |
III-IV | 0.303 (0.052–0.554) | 0.727 (0.527–0.927) | ||
Foxp3 staining value | ||||
1 | 0.474 (0.268–0.680) | 0.000*** | 0.701 (0.562–0.840) | 0.003** |
2 | 0.611 (0.499–0.723) | 0.795 (0.711–0.879) | ||
3 | 0.162 (0.074–0.250) | 0.330 (0.133–0.793) |